328 related articles for article (PubMed ID: 15291683)
1. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683
[TBL] [Abstract][Full Text] [Related]
2. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.
Zhang XY; Zhou DF; Shen YC; Zhang PY; Zhang WF; Liang J; Chen DC; Xiu MH; Kosten TA; Kosten TR
Neuropharmacology; 2012 Apr; 62(5-6):1928-34. PubMed ID: 22227558
[TBL] [Abstract][Full Text] [Related]
4. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
Zhang XY; Zhou DF; Qi LY; Chen S; Cao LY; Chen DC; Xiu MH; Wang F; Wu GY; Lu L; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2009 May; 204(1):177-84. PubMed ID: 19139851
[TBL] [Abstract][Full Text] [Related]
7. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.
Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC
Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
[TBL] [Abstract][Full Text] [Related]
9. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
Zhang XY; Zhou DF; Cao LY; Wu GY
Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
[TBL] [Abstract][Full Text] [Related]
10. Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.
See RE; Fido AA; Maurice M; Ibrahim MM; Salama GM
Biol Psychiatry; 1999 Jun; 45(12):1653-6. PubMed ID: 10376128
[TBL] [Abstract][Full Text] [Related]
11. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
12. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
13. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
[TBL] [Abstract][Full Text] [Related]
14. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
Rémillard S; Pourcher E; Cohen H
Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
[TBL] [Abstract][Full Text] [Related]
15. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
[TBL] [Abstract][Full Text] [Related]
16. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
Zhang L; Zheng H; Wu R; Zhu F; Kosten TR; Zhang XY; Zhao J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():69-76. PubMed ID: 29678772
[TBL] [Abstract][Full Text] [Related]
17. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
[TBL] [Abstract][Full Text] [Related]
19. Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Int Clin Psychopharmacol; 2001 Nov; 16(6):325-30. PubMed ID: 11712620
[TBL] [Abstract][Full Text] [Related]
20. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
